(MedPage Today) — The FDA approved etripamil (Cardamyst) nasal spray for at-home treatment of paroxysmal supraventricular tachycardia (PSVT), maker Milestone Pharmaceuticals announced.
The rapid-acting L-type calcium channel blocker is indicated…
Webinar on allied health and nursing to be held on May 11
With the growing demand for quality healthcare services, allied health and nursing professionals are playing an increasingly significant role in...






